Seroprevalence of tick-borne encephalitis virus in wild and domestic animals in northern Germany.


Journal

Ticks and tick-borne diseases
ISSN: 1877-9603
Titre abrégé: Ticks Tick Borne Dis
Pays: Netherlands
ID NLM: 101522599

Informations de publication

Date de publication:
11 2023
Historique:
received: 27 03 2023
revised: 07 06 2023
accepted: 18 06 2023
medline: 27 9 2023
pubmed: 26 6 2023
entrez: 25 6 2023
Statut: ppublish

Résumé

Tick-borne encephalitis virus (TBEV) is a tick-transmitted flavivirus, which can infect humans and animals, sometimes even with a fatal outcome. Since many decades, TBEV is endemic in southern Germany, while only sporadic occurrence has been noted in northern parts of the country so far. Nevertheless, autochthonous human clinical cases are increasing in the federal state of Lower Saxony in north-western Germany, and several natural foci of TBEV transmission have recently been detected in this federal state. In order to shed more light on the current distribution of TBEV in Lower Saxony, the present study examined blood samples from wild and domestic animals for antibodies against TBEV. Overall, samples from 4,085 animals were tested by ELISA, including wild boar (N = 1,208), roe deer (N = 149), red deer (N = 61), fallow deer (N = 18), red foxes (N = 9), nutria (N = 9), raccoon dogs (N = 3), raccoons (N = 3), badgers (N = 1), European pine martens (N = 1), horses (N = 574), sheep (N = 266), goats (N = 67), dogs (N = 1,317) and cats (N = 399). Samples with an ELISA result of ≥60 Vienna units (VIEU)/ml were subjected to confirmatory serum neutralization tests (SNT). In total, 343 of 4,085 (8.4%) animals tested positive for anti-TBEV-IgG by ELISA, of which 60 samples were confirmed by SNT. Samples of 89 animals showed a cytotoxic effect in the SNT and were excluded from seroprevalence calculation, resulting in an overall seroprevalence of 1.5% (60/3,996). Seroprevalence was higher among wild animals (wild boar: 2.9% [34/1,190], roe deer: 2.7% [4/149], red deer: 1.7% [1/60], fallow deer: 5.6% [1/18]) than among domestic animals (dogs: 1.1% [15/1,317], horses: 0.8% [4/505], sheep: 0.4% [1/266]). No anti-TBEV-antibodies were detected in the other wild animal species as well as goats and cats. A notable clustering of positive samples was observed in districts where TBEV transmission foci have been described. Further clusters in other districts suggest the existence of so far undetected transmission foci, underlining the fact that both wild and domestic animals are useful sentinels for monitoring the spread of TBEV.

Identifiants

pubmed: 37356181
pii: S1877-959X(23)00101-2
doi: 10.1016/j.ttbdis.2023.102220
pii:
doi:

Substances chimiques

Antibodies, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102220

Informations de copyright

Copyright © 2023. Published by Elsevier GmbH.

Déclaration de conflit d'intérêts

Declaration of Competing Interest SP is an employee of Elanco Deutschland GmbH, BS is an employee of Elanco Animal Health. Study data collection and interpretation is completely independent from the company's opinion and the authors declare that there is no conflict with commercial interests. The remaining authors declare that they have no competing interests.

Auteurs

Anna-Katharina Topp (AK)

Institute for Parasitology, Centre for Infection Medicine, University of Veterinary Medicine Hannover, Buenteweg 17, Hannover 30559, Germany.

Andrea Springer (A)

Institute for Parasitology, Centre for Infection Medicine, University of Veterinary Medicine Hannover, Buenteweg 17, Hannover 30559, Germany.

Reinhard Mischke (R)

Clinic for Small Animals, University of Veterinary Medicine Hannover, Hannover 30559, Germany.

Johanna Rieder (J)

Clinic for Small Animals, University of Veterinary Medicine Hannover, Hannover 30559, Germany.

Karsten Feige (K)

Clinic for Horses, University of Veterinary Medicine Hannover, Hannover 30559, Germany.

Martin Ganter (M)

Clinic for Swine and Small Ruminants, University of Veterinary Medicine Hannover, Hannover 30173, Germany.

Uschi Nagel-Kohl (U)

Lower Saxony State Office for Consumer Protection and Food Safety, Veterinary Institute Hannover, Hannover 30173, Germany.

Marcel Nordhoff (M)

Lower Saxony State Office for Consumer Protection and Food Safety, Food and Veterinary Institute Oldenburg, Oldenburg 26133, Germany.

Matthias Boelke (M)

Institute for Parasitology, Centre for Infection Medicine, University of Veterinary Medicine Hannover, Buenteweg 17, Hannover 30559, Germany.

Stefanie Becker (S)

Institute for Parasitology, Centre for Infection Medicine, University of Veterinary Medicine Hannover, Buenteweg 17, Hannover 30559, Germany.

Stefan Pachnicke (S)

Elanco Deutschland GmbH, Monheim am Rhein 40789, Germany.

Bettina Schunack (B)

Elanco Animal Health, Bayer Animal Health GmbH, Monheim 40789, Germany.

Gerhard Dobler (G)

National Reference Laboratory for TBEV, Bundeswehr Institute of Microbiology, Munich 80937, Germany.

Christina Strube (C)

Institute for Parasitology, Centre for Infection Medicine, University of Veterinary Medicine Hannover, Buenteweg 17, Hannover 30559, Germany. Electronic address: christina.strube@tiho-hannover.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH